When combined with diet and exercise modifications, retatrutide may assist individuals in losing additional weight and maintaining it
Noom users on a GLP-1 lose 1.4x more weight than those on medication alone*, and in Noom's largest randomized controlled trial of its digital behavior program, members lost an average of 4.1% of their body weight and kept losing for a full year after the program ended, while a control group gained weight
In REDEFINE 1, which enrolled 3,400 adults without diabetes but with at least one weight-related condition, CagriSema led to an average weight loss of 20.4% at Week 68 , compared to 14.9% with semaglutide, 11.5% with cagrilintide, and 3% with placebo
Can you speed up semaglutide clearance
In human phase 2 trials, retatrutide significantly reduced body weight